Specific features of the clinical manifestations of patent ductus arteriosus in extremely premature newborns
https://doi.org/10.21508/1027-4065-2016-61-1-51-55
Abstract
Objective: to establish the clinical and functional characteristics of extremely premature newborn infants with patent ductus arteriosus and prognostic criteria for its function after 72 hours of postnatal life to determine a differentiated treatment policy for this category of patients. Sixty-nine extremely premature neonates with very low (n=37) and extremely low (n=32) birth weight and patent ductus arteriosus were followed up. Physical, neurological, laboratory, and instrumental examinations were performed. It was established that hemodynamically significant patent ductus arteriosus was detectable in 79.7% of the cases on day 3 of life, in 50.9% on day 5, and in 15.9% at the end of the neonatal period. Specific features were found in these patients compared to patients with hemodynamic insignificant patent ductus arteriosus. They showed a lower gestational age, lower Apgar scores, neurological disorders, moist rale, and crepitation, an increased lung pattern due to interstitial and vascular components, as well as a propensity to have thrombocytopenia, the significantly higher mean values of the diastolic and systolic diameters of the left ventricle, left atrium, right ventricle, and aortic root. A procedure was developed to predict a poor trend in patent ductus arteriosus. Conclusion. Taking into account the clinical and functional characteristics of extremely premature neonatal infants permits the longterm persistence of patent ductus arteriosus to be predicted in them, which is of importance in defining a therapeutic policy.
About the Authors
E. M. SpivakRussian Federation
T. N. Nikolaeva
Russian Federation
A. M. Klimachev
Russian Federation
References
1. Волянюк Е.В. Гемодинамически значимый открытый артериальный проток у недоношенных новорожденных. Практическая медицина 2010; 6: 73–75. (Voljanjuk E.V. Hemodynamically significant patent ductus arteriosus in preterm infants. Prakticheskaja medicina 2010; 6: 73–75.)
2. Дягтерева М.В., Батищева И.Н., Воронцова Ю.Н. и др. Клинико-патогенетические особенности функционирующего артериального протока у недоношенных новорожденных детей и современные подходы к выбору тактики ведения. Вопр практич педиатр 2012; 7: 42– 51. (Djagtereva M.V., Batishheva I.N., Voroncova Ju.N. et al.. Clinical-pathogenic peculiarities of the functioning of the arterial ductus in preterm neonates and modern approaches to the choice of tactics. Vopr praktich pediatr 2012; 7: 42–51.)
3. Дегтярев Д.Н., Крючко Д.С., Антонов А.Г. и др. Протокол ведения недоношенных детей с гемодинамически значимым функционирующим артериальным протоком. М, 2009; 34. (Degterev D.N., Krjuchko D.S., Antonov A.G. et al. The records of premature infants with hemodynamically significant functioning arterial ductus. Moscow 2009; 34.)
4. Крючко Д.С., Антонов А.Г., Ленюшкина А.А. и др. Современные представления об открытом артериальном протоке у новорожденных. Педиатрия 2011; 1: 130–136. (Krjuchko D.S., Antonov A.G., Lenjushkina A.A. i dr. Modern ideas about the open arterial ductus in newborns. Pediatrija 2011; 1: 130–136.)
5. Cheng Han Lee, Hsiao-Neng Chen, Long-Yen Tsao et al. Oral ibuprofen versus intravenous indomethacin for closure of patent ductus arteriosus in very low birth weight infants. Pediatrics and Neonatology 2012; 6: 346–353.
6. Прахов А.А. Неонатальная кардиология. Нижний Новгород, 2008; 388. (Prahov A.A. Neonatal cardiology. Nizhnij Novgorod, 2008; 388.)
7. Hamrick S.E., Hansmann G. Patent Ductus arteriosus of preterm infant. Pediatrics 2010; 5: 1020–1030.
Review
For citations:
Spivak E.M., Nikolaeva T.N., Klimachev A.M. Specific features of the clinical manifestations of patent ductus arteriosus in extremely premature newborns. Rossiyskiy Vestnik Perinatologii i Pediatrii (Russian Bulletin of Perinatology and Pediatrics). 2016;61(1):51-55. (In Russ.) https://doi.org/10.21508/1027-4065-2016-61-1-51-55